Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-23T08:16:16.326Z Has data issue: false hasContentIssue false

Biological aspects of social phobia

Published online by Cambridge University Press:  18 September 2015

Summary

In contrast to the research in panic disorder, not much neurobiological studies have been conducted in social phobia. In challenge-tests using lactate or pentagastrin general anxiety and anxiety symptoms were induced in social phobies, although not as frequent is in panic disorder patients, but no specific social phobic anxiety was induced. The role of neurotransmitters such as serotonin, dopamine and noradrenalin is, as yet, unclear. There are no indications for abnormal hypothalamic-pituitary-adrenal-axis activity or abnormal hypothalamic-pituitary-thyroid-axis activity in social phobia. To the present, preliminary findings in neuroimaging studies show no differences between patients and controls, except a possibly diminished and reversible metabolic activity.

Type
Research Article
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literatuur

1.Tancer, ME, Lewis, MH, Stein, MB. Biological aspects of social phobia. In: Stein, MB, ed. Social phobia: clinical and research perspectives. American Psychiatric Press, Washington 1995:229-57.Google Scholar
2.Van Vliet, IM. Developments in the neurobiology and psychopharmacology of panic disorder and social phobia. Thesis. Utrecht 1996.Google Scholar
3.Van Vliet, IM, Den Boer, JA, Westenberg, HGM. De sociale fobie. In: Den Boer, JA & Westenberg, HGM, eds. Leerboek angststoornissen - een neurobiologische benadering. De Tijdstroom, Utrecht 1995, 234-67.Google Scholar